Clinical Scorecard: Evaluation of the Impact of Air Travel Volume on the Spread of COVID-19 and Influenza Under Different Public Health Measures, 2019–2024

At a Glance

Key Highlights

• Increased intercontinental flight volumes are significantly associated with higher influenza activity and COVID-19 case and mortality rates.
• The association between flight volume and disease transmission is stronger for COVID-19 than influenza and more pronounced in countries with less stringent public health measures.
• Targeted travel restrictions combined with appropriate public health interventions effectively reduce international spread of respiratory pathogens.

Guideline-Based Recommendations

Diagnosis

• Utilize laboratory testing and surveillance data to monitor influenza positivity rates and COVID-19 case counts.
• Incorporate population-adjusted rates for accurate cross-country and subnational comparisons.

Management

• Implement targeted aviation measures such as flight suspensions and enhanced testing to reduce importation risk.
• Combine travel restrictions with comprehensive public health and social measures to maximize impact on disease transmission.

Monitoring & Follow-up

• Use global and subnational surveillance platforms (e.g., WHO FluNet, WHO COVID-19 Dashboard, CDC data) for ongoing disease activity tracking.
• Apply indices like the Oxford COVID-19 Government Response Tracker to assess and adjust public health measure stringency.

Risks

• High flight volumes can accelerate the spread of respiratory pathogens, especially in settings with lax control measures.
• In-flight transmission and imported cases contribute to epidemic risk along major air travel corridors.

Patient & Prescribing Data

Populations in countries and US states with varying public health interventions during 2019–2024

Not applicable; study focuses on epidemiological impact of air travel on disease spread rather than individual patient treatment.

Clinical Best Practices

• Integrate travel volume data with epidemiological surveillance to inform public health decision-making.
• Adopt hierarchical modeling approaches to account for heterogeneity in public health measures when assessing transmission risk.
• Prioritize pathogen-specific strategies combining travel restrictions and public health interventions to mitigate international spread.

References

• WHO FluNet
• WHO COVID-19 Dashboard
• OAG Analyzer
• Oxford COVID-19 Government Response Tracker (OxCGRT)
• Centers for Disease Control and Prevention (CDC)